期刊文献+

EFFECTS OF ANTICOAGULATION PROTEIN DEFECT IN MATERNAL PLASMA ON SPONTANEOUS ABORTION 被引量:1

EFFECTS OF ANTICOAGULATION PROTEIN DEFECT IN MATERNAL PLASMA ON SPONTANEOUS ABORTION
下载PDF
导出
摘要 Objective To investigate the mechanism of anticoagulation protein defect in the pathogenesis of unexplained recurrent miscarriage. Methods Fifty-seven patients with a history of unexplained abortion were enrolled as the investigation group for tests of protein C, protein S, antithrombinⅢ(AT-Ⅲ), as well as activated protein C resistance (APC-R). The control group con-sisted of fifty healthy women with a history of normal pregnancy and delivery. Blood samples were obtained for measuring serum activity of protein C, protein S, AT-Ⅲ, and APC-R. Patients with positive APC-R were tested for factorⅤ(FⅤ) Lei-den gene mutation by PCR-RFLP method. Results Of the 57 patients, 12 (21.1%), 1 (1.8%), and 5 (8.8%) cases were found with protein S, protein C, and AT-Ⅲdeficiency respectively, and 13 (22.8%) cases with positive results of APC-R. Of the control group, no protein C or AT-Ⅲdeficiency was ever found, whereas 2 (4.0%) volunteers were presented with protein S deficiency and 3 (6.0%) with positive results of APC-R. No FⅤLeiden gene mutation was identified in all the patients with positive APC-R results. Late spontan-eous abortion cases had higher incidence of anticoagulation protein defect than the early cases. Conclusion Anticoagulation protein defect may play a role in the pathogenesis of fetal loss, especially for those occurr-ing in late stage of pregnancy.
机构地区 DepartmentofHematology
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2004年第4期290-292,共3页 中国医学科学杂志(英文版)
关键词 protein S deficiency protein C deficiency activated protein C resistance spontaneous abortion 抗凝血蛋白 母体血浆 自然流产 AT-Ⅲ APC-R
  • 相关文献

参考文献9

  • 1[1]Ament L. Factor Ⅴ Leiden: a review of the literature. J Perinat Neonatal Nurs 2003; 17:190-5.
  • 2[2]Cleary-Goldman J, Nakhuda GS, Zimmermarn RC, et al. The role of factor V Leiden mutation in recurrent pregnancy loss. J Am Med Womens Assoc 2003 ;58:165-72.
  • 3[3]Bloomenthal D, Delisle MF, Tessier F, et al. Obstetric implications of the factor Ⅴ leiden mutation: a review. Am J Perinatol 2002;19:37-47.
  • 4[4]Dahlback B, Carlsson M, Svensson PJ, et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
  • 5[5]Bertina RM, Koeleman PC, Koster T, et al. Mutation in blood coagnlation factor Ⅴ associated with resistance to activated protein C. Nature 1994;369:64-7.
  • 6[6]Preston FE, Rosendaal FR, Walker ZD, et al. Increased fetal loss in women with heritable thrombophillia. Lancet 1996;348:913-6.
  • 7[7]Tal J, Schliamser LM, Leibovitz Z, et al. A possible role for activated protein C resistance in patients with first and second trimestet pregnancy failure. Hum Reprod 1999; 14:1624-7.
  • 8[8]Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intraveassociated with antiphospholipid antibodies. Arthritis Rheum 2003;48:728-31.
  • 9[9]Younis JS, Ohel G, Brenner B, et al. The effect ofthrombophylaxis on pregnancy outcome in patients with recurrent pregn-ancy loss associated with factor Ⅴleiden mutation. BJOG 2000;107:415-9.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部